FDA Approved: ADALIMUMAB — Original Application (CELLTRION USA, Inc.)

View source ↗

Summary

FDA approved ADALIMUMAB-AATY from CELLTRION USA, Inc. as a biosimilar to adalimumab under an Original Application for the same indications as the reference prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Hidradenitis Suppurativa
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB-AATY (adalimumab)

Snippet

ORIG AP for ADALIMUMAB (ADALIMUMAB-AATY)